Clinical impact of COVID-19 on patients with choroidal neovascularization on intravitreal anti-VEGF therapy.

Agorogiannis, Eleftherios I; Maleedy, Deena; Hakim, Navid; McDaid, David; Silver, Laura; Madhusudhan, Savita; Beare, Nicholas A V

Agorogiannis, Eleftherios I; Maleedy, Deena; Hakim, Navid; McDaid, David; Silver, Laura; Madhusudhan, Savita; Beare, Nicholas A V.

Agorogiannis EI; St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK. eleftherios.agorogiannis@gmail.com.
Maleedy D; Moorfields Eye Hospital, London, UK. eleftherios.agorogiannis@gmail.com.
Hakim N; St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.
McDaid D; St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.
Silver L; St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.
Madhusudhan S; St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.
Beare NAV; St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.

Eye (Lond) ; 36(5): 1113-1114, 2022 05.

Article in English | MEDLINE | ID: covidwho-1333928

Subject(s)

COVID-19; Choroidal Neovascularization; Angiogenesis Inhibitors/therapeutic use; Bevacizumab/therapeutic use; Choroidal Neovascularization/drug therapy; Humans; Intravitreal Injections; Ranibizumab/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Choroidal Neovascularization / COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Eye (Lond) Journal subject: Ophthalmology Year: 2022 Document Type: Article Affiliation country: S41433-021-01698-5

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google